August 7, 2025DiseasesOpen Access

Association of Therapeutic Plasma Exchange-Treated Thrombotic Thrombocytopenic Purpura with Improved Mortality Outcome in End-Stage Renal Disease

View Full Paper

Ask AI

Bookmark

ESRD patients receiving therapeutic plasma exchange for TTP show lower mortality risk compared to those without this treatment.
A study of 1,155,136 patients found significant predictors of TTP diagnosis, including demographics and clinical comorbidities.
Cox proportional hazards models indicated an adjusted hazard ratio of 0.024 for death in TPE-treated individuals.
Results highlight the importance of timely therapeutic plasma exchange in improving survival among ESRD patients with TTP.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Cohort analysis reveals improved mortality outcomes in ESRD patients with therapeutic plasma exchange-treated TTP, suggesting significant protective benefits.

Cite This Study

Kincaid et al. (2025) studied this question.

synapsesocial.com/papers/689521e99f4f1c896c428671 https://doi.org/10.3390/diseases13080247

View Full Paper

Ask AI

Bookmark

Implication

Cohort analysis reveals improved mortality outcomes in ESRD patients with therapeutic plasma exchange-treated TTP, suggesting significant protective benefits.

Association of Therapeutic Plasma Exchange-Treated Thrombotic Thrombocytopenic Purpura with Improved Mortality Outcome in End-Stage Renal Disease

Key Points

Discussion

Implication

Cite This Study

Association of Therapeutic Plasma Exchange-Treated Thrombotic Thrombocytopenic Purpura with Improved Mortality Outcome in End-Stage Renal Disease

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider